about
Gone to Pot - A Review of the Association between Cannabis and PsychosisMarijuana Legalization: Impact on Physicians and Public HealthFeasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.Asian Indians in America: The influence of values and culture on mental health.Development of a Diverse Learning Experience for Diverse Psychiatry Resident Needs: A Four-Year Biological Psychiatry Curriculum Incorporating Principles of Neurobiology, Psychopharmacology, and Evidence-Based Practice.Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia.Impact of Cannabis Use on the Development of Psychotic DisordersPrayer, randomized controlled trials and distance healing: A response to Dr. Jana.Psychopharmacology of schizophrenia: The Future Looks Bleak.Domains and determinants of quality of life in schizophrenia and systemic lupus erythematosusA Meta-analytic Review of Non-specific Effects in Randomized Controlled Trials of Cognitive Remediation for SchizophreniaSuicide: An Indian perspectiveAcute effects of THC on time perception in frequent and infrequent cannabis usersGABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC.The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments.Thyroid dysfunction in major psychiatric disorders in a hospital based sample.Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.Human Laboratory Studies on Cannabinoids and Psychosis.Neuropsychiatric aspects of concussion.A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications.Reflections on an Innovation: The First Trainee-Led Academic Psychiatry Journal.Editorial training models for early-career psychiatrists.The Link Between the Immune System, Environment, and Psychosis.Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.Body mass index identified as an independent predictor of psychiatric readmission.From "Azalla" to Anandamide: Distilling the Therapeutic Potential of Cannabinoids.2015 in Review.Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.Maintenance electroconvulsive therapy: implementing the STABLE algorithm.Cannabinoids and Psychosis.Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis Syndrome.The Psychiatric Consequences of Cannabinoids.Age-related change in 5-HT6 receptor availability in healthy male volunteers measured with 11C-GSK215083 PET.T115. REASONING BIAS, WORKING MEMORY PERFORMANCE, AND A TRANSDIAGNOSTIC PHENOTYPE OF AFFECTIVE DISTURBANCES AND PSYCHOTIC EXPERIENCES IN THE GENERAL POPULATION.Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulationAssociation between unconjugated bilirubin and schizophreniaThe American Journal of Psychiatry Residents' Journal: Training the Next Generation of Academic PsychiatristsEfficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trialGrey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in AdolescenceReasoning bias, working memory performance and a transdiagnostic phenotype of affective disturbances and psychotic experiences in the general population
P50
Q26865311-9FB07C09-BA40-42C1-992B-13DE5F4C88C5Q28082785-84DE2E19-4145-4C86-86B7-B9EEF3769A0DQ28277784-65FA9ADA-CC50-4E49-8DFC-AD74B4CAF0CEQ30252083-882D552D-C98D-4153-A266-A326DE045BE0Q33715038-A3940F19-092B-4C35-81BA-8BEC18714EE3Q34571959-8C681954-81B4-4F1F-9D38-482B22291AA8Q34668606-8F461353-54F2-4FEC-81A0-75B7EBECFD40Q35564554-ECCF44F5-7280-4582-B854-80BD8509675BQ35964364-5D37383C-AACC-4FEF-9395-66879F4BFD8EQ35993147-5216E38C-AAA0-49C2-A472-730EC8A60B6FQ36260429-9FB62D00-9E48-4397-BA6F-A68FCF2B26D4Q36562174-CECEE308-29CF-4977-99E4-904B531C64E0Q36636653-A851DAF0-C012-4DEB-90DC-779F9501D81BQ36821827-96EBA9CB-B315-4CF8-BCAC-EEF745DCF409Q37334202-4AE0D55C-B779-41B1-BE6C-5317DFDF46F3Q37690833-C880972D-3DC2-4CC2-9E3F-6B2BA9AB89E2Q38667824-D20B8456-0F2D-4063-B2DC-953C2264D3E1Q38771523-7E8487E7-A10F-4AF5-B2E2-392D777D786DQ38790539-A81E71C1-A95C-4100-B314-861C88409A50Q38937106-8619B499-AE37-46D8-AFEB-B654E89B291FQ43953672-AE59F253-DECE-4381-9413-B062A15EA42BQ46256926-03EAF06B-E37B-4578-A3CD-8866437755C4Q47669884-34978DC1-0989-4A82-9328-086237458111Q47930409-2E81B0E8-3FA6-4F90-A20B-B7CE09886158Q48258560-0DBE091C-B8F6-44D8-A6D2-319B73B6D181Q49240432-AE75DD70-13DA-4B85-ABD4-C3383B6748DAQ50552323-D5179C1C-81D6-46DF-B76D-BD449C18218DQ50594258-39E747ED-46C0-4BF7-9451-97B9A8C8DD19Q51795682-70C2C175-BA18-4325-B31E-60B654429302Q51834827-3C502AAD-9EF5-4BCB-8B8F-656F6EB4F7E8Q52559088-CD4602CD-AE35-4D0B-9349-ED18C90A2EE5Q52573865-292F4D53-B832-46D8-9DFE-8D1318AA7DA3Q52601676-B0B800D6-BF2B-47E3-AA8F-0D455A563D6EQ55381151-440E2807-5CAF-44B0-B0E5-EB51AC41ADBEQ57031589-3589AFE5-F33D-43E6-82EF-4E65951B557BQ83796975-92B2EE56-1477-4F38-909B-0EBC09D3B505Q89344932-95A020DB-C8C4-45E7-9086-38C896CB62B9Q90353844-2A87AAA5-BC69-4742-96F5-BA654B416813Q91044801-98A4D130-9B6E-4674-8924-B8F9972BC300Q91218920-C6518244-F60F-4C26-B26B-808555CF3387
P50
description
researcher ORCID ID = 0000-0002-8220-655X
@en
wetenschapper
@nl
name
Rajiv Radhakrishnan
@ast
Rajiv Radhakrishnan
@en
Rajiv Radhakrishnan
@es
Rajiv Radhakrishnan
@nl
type
label
Rajiv Radhakrishnan
@ast
Rajiv Radhakrishnan
@en
Rajiv Radhakrishnan
@es
Rajiv Radhakrishnan
@nl
prefLabel
Rajiv Radhakrishnan
@ast
Rajiv Radhakrishnan
@en
Rajiv Radhakrishnan
@es
Rajiv Radhakrishnan
@nl
P31
P496
0000-0002-8220-655X